Melanoma skin cancer statistics

Cases

New cases of melanoma skin cancer, 2014-2016 average, UK

Deaths

Deaths from melanoma skin cancer, 2016, UK

Survival

Survive melanoma skin cancer for 10 or more years, 2010-11, England and Wales

Preventable cases

Melanoma skin cancer cases are preventable, UK, 2015

 

  • There are around 16,000 new melanoma skin cancer cases in the UK every year, that's 44 every day (2014-2016).
  • Melanoma skin cancer is the 5th most common cancer in the UK, accounting for 5% of all new cancer cases (2016).
  • In females in the UK, melanoma skin cancer is the 5th most common cancer, with around 8,300 new cases in 2016.
  • In males in the UK, melanoma skin cancer is the 5th most common cancer, with around 8,100 new cases in 2016.
  • Incidence rates for melanoma skin cancer in the UK are highest in people aged 85 to 89 (2014-2016).
  • Since the early 1990s, melanoma skin cancer incidence rates have more than doubled (134%) in the UK. Rates in females have increased by two times (100%) and rates in males have almost tripled (181%).
  • Over the last decade, melanoma skin cancer incidence rates have increased by almost half (45%) in the UK. Rates in females have increased by more than a third (35%), and rates in males have increased by almost three-fifths (55%).
  • Around 1 in 10 melanoma skin cancer cases are diagnosed at a late stage in England (2012-2013).
  • Most melanoma skin cancers occur in the trunk or legs.
  • Incidence rates for melanoma skin cancer are projected to rise by 7% in the UK between 2014 and 2035, to 32 cases per 100,000 people by 2035.
  • Melanoma skin cancer in England is less common in people living in the most deprived areas.
  • Melanoma skin cancer is most common in White people than Asian or Black people.
  • An estimated 110,300 people who had previously been diagnosed with melanoma skin cancer were alive in the UK at the end of 2010.

See more in-depth melanoma skin cancer incidence statistics

  • There are around 2,400 melanoma skin cancer deaths in the UK every year, that's more than 6 every day (2014-2016).
  • Melanoma skin cancer is the 20th most common cause of cancer death in the UK, accounting for 1% of all cancer deaths (2016).
  • In males in the UK, melanoma skin cancer is the 17th most common cause of cancer death, with around 1,400 deaths in 2016.
  • In females in the UK, melanoma skin cancer is the 18th most common cause of cancer death, with around 930 deaths in 2016.
  • Mortality rates for melanoma skin cancer in the UK are highest in people aged 90+ (2014-2016).
  • Since the early 1970s, melanoma skin cancer mortality rates have increased by around two-and-a-half times (156%) in the UK. Rates in males have increased by around three-and-a-half times (247%), and rates in females have increased by around four-fifths (81%).
  • Over the last decade, melanoma skin cancer mortality rates have increased by around a seventh (14%) in the UK. Rates in males have increased by around a fifth (19%), and rates in females have remained stable.
  • Mortality rates for melanoma skin are projected to fall by 15% in the UK between 2014 and 2035, to 4 deaths per 100,000 people by 2035.
  • Melanoma skin cancer deaths are less common in males living in the most deprived areas.

See more in-depth melanoma skin cancer mortality statistics

  • 9 in 10 (90%) people diagnosed with melanoma skin cancer in England and Wales survive their disease for ten years or more (2010-11).
  • 9 in 10 (90%) people diagnosed with melanoma skin cancer in England and Wales survive their disease for five years or more (2010-11).
  • Nearly all (97%) people diagnosed with melanoma skin cancer in England and Wales survive their disease for one year or more (2010-11).
  • Melanoma skin cancer survival is higher in women than men.
  • 95% of people in England diagnosed with melanoma skin cancer aged 15-39 survive their disease for five years or more, compared with more than 8 in 10 people diagnosed aged 80 and over (2009-2013).
  • Melanoma skin cancer survival is improving and has doubled in the last 40 years in the UK.
  • In the 1970s, almost half of people diagnosed with melanoma skin cancer survived their disease beyond ten years, now it's 9 in 10.
  • When diagnosed at its earliest stage, all people with melanoma skin cancer will survive their disease for five years or more, compared with a quarter of women and less than a tenth of men when diagnosed at the latest stage.
  • Five-year relative survival for melanoma skin cancer in men is above the European average in England, Scotland and Northern Ireland but below the European average in Wales.
  • Five-year relative survival for melanoma skin cancer in women is above the European average in England, Scotland and Northern Ireland but similar to the European average in Wales.

See more in-depth melanoma skin cancer survival statistics

  • A person’s risk of developing cancer depends on many factors, including age, genetics, and exposure to risk factors (including some potentially avoidable lifestyle factors).
  • 1 in 36 UK males and 1 in 47 UK females will be diagnosed with melanoma skin cancer in their lifetime.
  • 86% of melanoma skin cancer cases in the UK are preventable.

See more in-depth melanoma skin cancer risk statistics

  • 'Two-week wait' is the most common route to diagnosing melanoma skin cancer.
  • 'Two-week wait' is the route with the highest proportion of cases diagnosed at an early stage, for melanoma skin cancer.
  • ‘Two week wait’ standards are met by all countries and ’31 day wait’ and ’62 day wait’ are met by all but Northern Ireland, for skin cancer.
  • Most patients with melanoma skin cancer are treated with surgery.

See more in-depth melanoma skin cancer diagnosis and treatment statistics

Want the key stats in the sections on this page as a document? or looking for a stats report of the in-depth stats? Use the print function at the bottom of any Cancer Stats page Share this page > Print or your browser options to print or save.

Citation

You are welcome to reuse this Cancer Research UK content for your own work.
Credit us as authors by referencing Cancer Research UK as the primary source. Suggested styles are:

Web content: Cancer Research UK, full URL of the page, Accessed [month] [year].
Publications: Cancer Research UK ([year of publication]), Name of publication, Cancer Research UK.
Graphics (when reused unaltered): Credit: Cancer Research UK.
Graphics (when recreated with differences): Based on a graphic created by Cancer Research UK.

When Cancer Research UK material is used for commercial reasons, we encourage a donation to our life-saving research.
Send a cheque payable to Cancer Research UK to: Cancer Research UK, Angel Building, 407 St John Street, London, EC1V 4AD or

Donate online

We’re now on twitter.

Join the conversation and follow @CRUKHCPs for news, updates and opinion.

@CRUKHCPs

Acknowledgements

We are grateful to the many organisations across the UK which collect, analyse, and share the data which we use, and to the patients and public who consent for their data to be used. Find out more about the sources which are essential for our statistics.